| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Galectin Therapeutics Inc. (GALT) have been net sellers, shedding 98,287 shares worth roughly $496K on balance. In the past 30 days, 0 insiders bought and 1 sold. Sales set the recent tone.
On the other side, 1 insider reduced a position over the period. GALT sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 5.61M | $19.37M | - | |
| CFO | 100.0K | $345.0K | - | |
| CEO | 100.0K | $345.0K | - | |
| Dir | 60.0K | $207.0K | - | |
| Dir | 60.0K | $207.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 19, 2020 | Freeman Kevin D57 | Director | Buy | 6,000 | $1.64 | $9,844.20 | +42.9% | |
| Jan 17, 2020 | 10x Fund, L.P.85 | 10% Owner | Sell | 10,000 | $2.97 | $29,700.00 | -0.2% | |
| Nov 15, 2019 | Freeman Kevin D57 | Director | Buy | 3,000 | $3.36 | $10,075.80 | +27.3% | |
| Oct 10, 2019 | 10x Fund, L.P.85 | 10% Owner | Sell | 17,000 | $3.73 | $63,325.00 | -0.3% | |
| Sep 6, 2019 | Freeman Kevin D57 | Director | Buy | 1,290 | $3.71 | $4,785.90 | +13.3% | |
| Sep 5, 2019 | Amelio Gilbert F | Director | Sell | 30,000 | $3.30 | $99,000.00 | -19.4% | |
| May 31, 2019 | Freeman Kevin D57 | Director | Buy | 9,136 | $4.28 | $39,102.08 | +38.0% | |
| May 31, 2019 | Lewis Joel | Director | Buy | 12,849 | $4.28 | $54,993.72 | +19.5% | |
| May 31, 2019 | Eldred Kary81 | Director | Buy | 3,033 | $4.28 | $12,981.24 | +7.3% | |
| May 31, 2019 | Callicutt Jack W62 | Chief Financial Officer | Buy | 2,354 | $4.28 | $10,075.12 | +186.8% |